Fda clears application for phase ii trial of viralclear’s merimepodib to treat covid-19

Fda clears the investigational new drug application to enable the phase ii trial of viralclear’s merimepodib, oral solution to treat adult patients with advanced covid-19, to proceed.biosig technologies inc - phase ii clinical trial expected to be conducted at multiple centers in united states.

BSGM Ratings Summary

BSGM Quant Ranking